India, Feb. 5 -- The Government of India has issued a release:
The outcomes of public R&D expenditure are periodically evaluated through various mechanisms. One such study titled "Evaluation of Innovation Excellence Indicators" has been recently conducted by the Office of the Principal Scientific Adviser to the Government of India which evaluated outcomes of the 233 public-funded R&D laboratories/institutes spread across the country. The report highlights that during 2021-22 and 2022-23, a total of 1,622 patents were filed by 233 public-funded R&D institutes, while 1,356 patents were granted to 232 institutes. In addition, 1,839 technologies were transferred, 1,014 new products were developed, and 1,746 new services were introduced over the two-year period. Furthermore, the outcomes of all central sector schemes/programmes are being evaluated through the Output-Outcome Monitoring Framework (OOMF) coordinated by NITI Aayog. Also, third-party evaluation of various central sector schemes/programmes has been carried out for their continuation during the 16th Finance Commission period i.e. 2026-27 to 2030-31.
As part of the strategy to improve technology commercialization, industry collaboration and private sector R&D participation, the government has taken several new initiatives through programmes/schemes, missions and policy interventions. These are:
All these measures aim to boost technology commercialization, foster industry partnerships and expand private sector participation in national R&D.
Disclaimer: Curated by HT Syndication.
